Stemtech Corporation
STEK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $5 | $4 |
| % Growth | 2.7% | 7.9% | 5.5% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $4 | $4 | $3 | $3 |
| % Margin | 73.8% | 79.6% | 74.5% | 76.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $6 | $7 | $5 |
| SG&A Expenses | $5 | $7 | $8 | $7 |
| Sales & Mktg Exp. | $0 | $1 | $2 | $2 |
| Other Operating Expenses | $1 | $1 | $0 | $0 |
| Operating Expenses | $6 | $8 | $8 | $7 |
| Operating Income | -$2 | -$4 | -$5 | -$3 |
| % Margin | -47.2% | -85.8% | -110.2% | -74.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$4 | -$4 |
| Pre-Tax Income | -$4 | -$5 | -$9 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$5 | -$9 | -$15 |
| % Margin | -74.6% | -110.3% | -189.3% | -353.7% |
| EPS | -0.032 | -0.065 | -0.19 | -0.41 |
| % Growth | 51.2% | 65.7% | 53.7% | – |
| EPS Diluted | -0.032 | -0.065 | -0.19 | -0.41 |
| Weighted Avg Shares Out | 119 | 83 | 45 | 38 |
| Weighted Avg Shares Out Dil | 119 | 83 | 46 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $5 | $4 | $8 |
| Depreciation & Amortization | $0 | $1 | $0 | $0 |
| EBITDA | -$2 | $0 | -$4 | $2 |
| % Margin | -35.2% | 1% | -87.6% | 35.8% |